fosinopril has been researched along with Obesity in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ashcheulova, T; Demydenko, G; Gerasimchuk, N; Kochubiei, O; Rezunenko, Y | 1 |
Drozd, VIu; Haĭdychuk, VS; Khukhlina, OS; Kosar, LIu; Mandryk, OIe | 1 |
Gapon, LI; Pliusnin, AV; Popova, SN; Veber, EE; Vershinina, AM | 1 |
Galimany, R; Higueruelo, S; Pastor, C; Romero, R; Vaquero, M | 1 |
Aguilar-Salinas, CA; Arellano, SA; Gómez-Pérez, FJ; Guillén-Pineda, LE; Magos, GA; Rodriguez, R; Villanueva-Sanchez, O | 1 |
1 trial(s) available for fosinopril and Obesity
Article | Year |
---|---|
[Effects of ACE inhibitor fosinopril on a 24-h profile of arterial pressure in hypertensive patients with obesity and hypercholesterolemia].
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Drug Administration Schedule; Female; Fosinopril; Humans; Hypercholesterolemia; Hypertension; Male; Metoprolol; Middle Aged; Obesity | 2005 |
4 other study(ies) available for fosinopril and Obesity
Article | Year |
---|---|
PATHOGENETIC ADVANCES OF FOSINOPRIL SODIUM WITH HYDROCHLOROTHIAZIDE IN OBESE HYPERTENSIVE PATIENTS.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Case-Control Studies; Dinoprost; Diuretics; Drug Therapy, Combination; Endothelium, Vascular; Essential Hypertension; Female; Fosinopril; Humans; Hydrochlorothiazide; Male; Middle Aged; Nitric Oxide Synthase Type II; Obesity; Overweight; Receptors, Tumor Necrosis Factor, Type I; Tumor Necrosis Factor-alpha | 2017 |
[The use of complex tools ezetimibe, hepadyfu fosinopril and correction of blood pressure and endothelial dysfunction in patients with nonalcoholic steatohepatitis and essential hypertension stage II].
Topics: Adenine; Anticholesteremic Agents; Azetidines; Carnitine; Drug Combinations; Endothelium, Vascular; Essential Hypertension; Ezetimibe; Fosinopril; Humans; Hypertension; Non-alcoholic Fatty Liver Disease; Obesity; Vascular Diseases | 2014 |
Fosinopril ameliorates exogenous cholesterol-induced incipient glomerular lesions in obese Zucker rats. Effects on eicosanoid secretion.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cholesterol; Cholesterol, Dietary; Eicosanoids; Fosinopril; Kidney Glomerulus; Obesity; Proteinuria; Rats; Rats, Zucker | 1998 |
Effects of omapatrilat on blood pressure and insulin sensitivity in an animal model of insulin resistance.
Topics: Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Double-Blind Method; Fosinopril; Glucose Tolerance Test; Insulin; Insulin Resistance; Male; Models, Animal; Obesity; Pyridines; Rats; Rats, Zucker; Thiazepines; Triglycerides | 2001 |